newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Reports Second Quarter 2024 Financial Results

-- FDA PDUFA Action Date of October 25, 2024; Advisory Committee Meeting on September 9, 2024— --Cash Runway into 2025, including through PDUFA Action Date-- --Company to Host Conference Call Today at 8:30 a.m.